Condition: Head and Neck Cancer · Hypoxia · FMISO · Sponsor: University Hospital Olomouc
Hypoxia occurs in about 80% of head and neck tumors. Based on experimental and clinical data, hypoxia is a useful parameter for pretherapeutic stratification. These radioresistant regions can be detected with FMISO PET/CT. Moreover, hypoxic subvolumes of tumors can be evolving as target volumes for radiotherapy ("dose painting") in hypoxia imaging-based dose escalation.
This description comes directly from the study's public registry record.
Martin Dolezel, Prof · +420588444295 · dolezelm@email.cz
Always discuss trial participation with your own doctor first.
| The Masaryk Memorial Cancer Institute | Brno, Czechia | Recruiting |
| Radiation oncology department in Palacký University and University Hospital Olomouc | Olomouc, Czechia | Recruiting |
| Faculty Hospital Ostrava | Ostrava, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05348486